Assembly Biosciences Dividends
| ASMB Stock | USD 27.05 1.19 4.21% |
As of February 5, 2026, Dividend Paid And Capex Coverage Ratio is expected to decline to -1,725. Assembly Biosciences' past performance could be the main factor of why investors trade Assembly Biosciences stock today. Investors should clearly understand every aspect of the Assembly Biosciences dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Assembly Biosciences' dividend schedule and payout information. Assembly Biosciences dividends can also provide a clue to the current valuation of Assembly Biosciences.
| Last Reported | Projected for Next Year | ||
| Dividend Paid And Capex Coverage Ratio | -1.6 K | -1.7 K |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Assembly Biosciences must own a stock before its ex-dividend date to receive its next dividend.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Assembly Biosciences. If investors know Assembly will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Assembly Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (4.60) | Revenue Per Share | Quarterly Revenue Growth 0.576 | Return On Assets | Return On Equity |
Assembly Biosciences's market price often diverges from its book value, the accounting figure shown on Assembly's balance sheet. Smart investors calculate Assembly Biosciences' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Assembly Biosciences' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that Assembly Biosciences' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Assembly Biosciences represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, Assembly Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.